In vitro induction of protein complexes between bevacizumab, VEGF-A(165) and heparin: explanation for deposits observed on endothelial veins in monkey eyes

Julien, Sylvie; Biesemeier, Antje; Schraermeyer, Ulrich

dc.contributor.author	Julien-Schraermeyer, Sylvie
dc.contributor.author	Biesemeier, Antje
dc.contributor.author	Schraermeyer, Ulrich
dc.date.accessioned	2013-12-16T09:32:41Z
dc.date.available	2013-12-16T09:32:41Z
dc.date.issued	2013
dc.identifier.issn	0007-1161
dc.identifier.uri	http://hdl.handle.net/10900/39614
dc.language.iso	en	en
dc.publisher	Bmj Publishing Group	de_DE
dc.relation.uri	http://dx.doi.org/10.1136/bjophthalmol-2012-302308	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	In vitro induction of protein complexes between bevacizumab, VEGF-A(165) and heparin: explanation for deposits observed on endothelial veins in monkey eyes	de_DE
dc.type	Article	de_DE
utue.quellen.id	20130911224530_01336	de_DE
utue.publikation.seiten	511-517	de_DE
utue.personen.roh	Julien, Sylvie
utue.personen.roh	Biesemeier, Antje
utue.personen.roh	Schraermeyer, Ulrich
dcterms.isPartOf.ZSTitelID	British Journal of Ophthalmology	de_DE
dcterms.isPartOf.ZS-Issue	4	de_DE
dcterms.isPartOf.ZS-Volume	97	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE